Dec 30

Daily Market Commentary : 30th Dec. 2016

The Indian stock market ended with smart gains on Friday(30th Dec. 2016) as investors sentiments were buoyed by rupee appreciation. U.S. dollar weakened, while crude oil prices rebounded in Asian trade.

The buying was so fierce that not a single sectoral index on the NSE ended with losses; FMCG, realty, pharma, IT, banking, media, financial services and auto stocks ended among the top gainers. Even the mid-cap and the small-cap stocks participated in today’s rally.

NSE Nifty closed 82 points higher at 8,186 points, while BSE Sensex ended with a gain of 260 points at 26,626.

Of the five pharmaceutical stocks that are both on the Nifty 50 and Nifty Pharma, the shares of Aurobindo Pharma and Sun Pharmaceutical Industries declined 24% each in 2016. While shares of Lupin declined 19%, those of Cipla fell 12% and Dr. Reddy’s Laboratories fell nearly 2% in 2016.

The Nifty PSU Bank index closed higher by 1.14% despite the Reserve Bank of India’s warning that the bad loans of state run banks may surge up to 10.1% by March 2018. The Nifty PSU Bank index is trading up 1.2% at 2,984. The Nifty PSU Bank index opened at 2,951 and hit a high of 3,002 and a low of 2,946.

On the global front, Asian markets closed mostly in green on Friday, the last trading day of 2016, despite the modest losses posted overnight on Wall Street. The Shanghai Composite index was up 0.24% and Hong Kong’s Hang Seng index closed higher by 1%. Nikkei 225 ended lower.

In Europe, the FTSE 100 is trading in red. CAC 40 and DAX are trading down by 0.2% each.

Aurobindo Pharma zoomed 3.2% after the company received US Food and Drug Administration’s (USFDA) approval for two of its generic drugs, following which the company stocks gained positive traction.

Engineers India fell 9.8% on the BSE after the stock turned ex bonus. The company announced that the shareholders of the company will get one free share for one held.

L&T Finance Holdings rallied 3% on the BSE after Harsh Mariwala bought 46,000 shares in the company.

Havells India gained 4.5% to Rs 339.25 on the BSE. Around 2.2 million shares of the company changed hands in a single block deal.

Sugar stocks gained the most in four months after the reports suggested that government was considering debt recast plans for the companies. Stocks like Dalmia Bharat Sugar, Bajaj Hindusthan, Dwarikesh Sugar and Dhampur Sugar saw gains between 6-10%.

Jagran Prakashan rallied 3.4% to Rs 179.85 after the company said the meeting of the board of directors is scheduled to be held on Jan 5,  2017 to consider the proposal for buyback of shares.

RS Software climbed 2%. RS Software has announced that the company has made further investment of Rs 5,90,00,000 in Paypermint Private Limited, its wholly owned subsidiary for allotment of 59,00,000 equity shares of 10 each.

GE Power India soared 5.3% after the company announced that it has received contracts worth $40 million by Bharat Heavy Electricals to supply components and services for the supercritical steam generator island packages for 2×800 MW coal-based Uppur Thermal Power Project and 1x800MW coal-based North Chennai Supercritical Thermal Power Project Stage-III. Both the thermal power projects are located in the southern state of Tamil Nadu. This is in line with the goverment.

Golden Tobacco closed on a flat note. Golden Tobacco Ltd said that it has received notice from a consortium of banks led by Canara Bank for one of its properties situated at Guntur.

IFCI slipped 3%. Term lender IFCI on Thursday said it has proposed to sell around 0.8% stake in National Stock Exchange (NSE).

The rupee was trading up 19 paise at 67.90 per US dollar.

Out of 1,539 stocks traded on the NSE, 414 declined and 941 advanced today.

Top 5 Nifty Gainers: Sun Pharma (2.39%), GAIL (2.38%), ITC Ltd. (2.25%), Infosys Ltd. (1.70%) and BHEL (1.60%).

Top 5 Nifty Losers: Bajaj Auto (-0.62%), Tata Steel (-0.50%), Dr. Reddys Lab (-0.46%), HDFC Bank (-0.12%) and ONGC (-0.03%)

To qualify NCFM Capital Market Dealers Module certification examination, register with Intelivisto.com and buy Capital Market comprehensive question bank which features mock test, chapter-wise and full length test as per NCFM standards. It also includes performance analysis tools to analyze the performance. For more information call on: +91-9891224488.

Dec 30

Daily Market Commentary : 29th Dec. 2016

After opening with modest gains, indices remained under pressure in the first half. The key benchmark climbed on the last day of the December series as investors prepared to close out a volatile year for financial markets. However, as the day progressed, late bout of buying in the auto, metal and IT stocks lifted the benchmarks.

Short-covering on the back of futures and options (F&O) expiry and a rupee appreciation buoyed the Indian equity markets during the mid-afternoon trade session on Thursday.

Besides, budgetary expectations and value buying enhanced investors’ risk-taking appetite, though negative global cues hampered the upward movement.

Sentiments got some support with report that the Cabinet Committee on Economic Affairs (CCEA) gave approval for over Rs 11,000 crore projects to improve rural road connectivity in the worst-affected left-wing extremism (LWE) districts from security angle.

NSE Nifty closed with a gain of 69 points at 8,104, while BSE Sensex ended with a gain of 155 points at 26,366.

On the global front, Asian markets closed on a mixed trend, as the crude oil prices slipped after touching its highest level in more than a year overnight. The Nikkei 225 ended lower by 1%. Shanghai Composite ended in red and Hong Kong’s Hang Seng index index closed slightly higher.

European stocks trading in red. The FTSE 100, DAX and the CAC 40 were trading marginally down.

The Nifty IT index, which has fallen 9% so far this year, was 0.9% higher with Tech Mahindra and TCS as the top percentage gainers.

Shares of some pharmaceutical companies came under pressure after media report that the National Pharmaceutical Pricing Authority may bring rest of the 814 essential formulations under price control in the current financial year ending in March. Divis Lab fell 4.8%, whereas Glenmark, Sun Pharma and Aurobindo Pharma dropped 1% respectively.

Shares of IDBI Bank and IFCI gained on news of NSE filing papers with Sebi for its IPO. IFCI zoomed 13.4% on the BSE.

IRB Infrastructure gained 2.2% after the company has received Letter of Award from NHAI for the project of six laning of Kishangarh to Gulabpura section of NH 79A and NH 79 in the State of Rajasthan (length 90.000 km) on DBFOT (Toll) under NHDP Phase V package -I Project.

JMC Projects rallied 8% after company secured new orders worth over Rs 1,457 crore.

Pratibha Industries zoomed 11.5%. The company’s board to meet on January 4, 2017 to approve the issue and allotment of shares on preferential basis to the lenders of the company under strategic debt restructuring (SDR) scheme.

Phoenix Mills rose 2%. The company on Wednesday said it has acquired the remaining 8.72% stake in its wholly-owned subsidiary Island Star Mall Developers Pvt Ltd (ISMDPL).

Rajesh Exports advanced 1.4% after the company has received an export order worth Rs 929 crore for designer gold and diamond studded jewellery. The order is to be executed by March, the company said.

Goa Carbon rallied 3%. The company on Wednesday informed bourses that the operations at Bilaspur Plant have commenced from December 27, 2016.

The rupee was trading up 14 paise at 68.09 per US dollar.

Out of 1,379 stocks traded on the NSE, 390 declined and 927advanced today.

Top 5 Nifty Gainers: BHEL (1.76%), ITC Ltd. (1.49%), SBI (1.45%), ICICI Bank (1.43%) and Axis Bank (1.20%).

Top 5 Nifty Losers: Bharti Airtel (-0.53%), Tata Motors (-0.37%), Coal India (-0.28%) and Dr. Reddys Lab (-0.19%)

To qualify NCFM Capital Market Dealers Module certification examination, register with Intelivisto.com and buy Capital Market comprehensive question bank which features mock test, chapter-wise and full length test as per NCFM standards. It also includes performance analysis tools to analyze the performance. For more information call on: +91-9891224488.